RHODOS Follow-up Single-visit Study (RHODOS-OFU)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Santhera Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01421381
First received: August 19, 2011
Last updated: May 24, 2013
Last verified: May 2013

August 19, 2011
May 24, 2013
September 2011
November 2011   (final data collection date for primary outcome measure)
logMAR visual acuity [ Time Frame: measure taken at the single study visit (Week 24) ] [ Designated as safety issue: No ]
Change in best logMAR visual acuity (Best Acuity) compared to Visit 2/Baseline and Visit 5/Week 24 or last treatment visit of SNT-II-003
Same as current
Complete list of historical versions of study NCT01421381 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
RHODOS Follow-up Single-visit Study
A Single Visit, Observational, Follow-up Study of Patients With Leber's Hereditary Optic Neuropathy Following Participation in SNT-II-003 Trial

This study aims to evaluate the current visual acuity of SNT-II-003 participants and compare this with the last visit from the SNT-II-003 study.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Patients who participated in study SNT-II-003

Leber's Hereditary Optic Neuropathy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
60
December 2011
November 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Previous participation in study SNT-II-003
Both
15 Years to 69 Years
No
Contact information is only displayed when the study is recruiting subjects
Canada,   Germany,   United Kingdom
 
NCT01421381
SNT-II-003-OFU
Not Provided
Santhera Pharmaceuticals
Santhera Pharmaceuticals
Not Provided
Principal Investigator: Patrick Chinnery, MD Clinical Research Facility
Santhera Pharmaceuticals
May 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP